Playing Game to Learn About Children's Vaccine Project
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age11-14
SponsorMichigan State University
About this trial
This proposed study aims to conduct timely research that promotes vaccine confidence and vaccination of one strongly recommended vaccine with suboptimal uptake rates: Human papillomavirus (HPV) in vulnerable and underserved youth aged 11-14.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Child sample: (1) 11-14 years old, (2) speaks and reads English, (3) has never received any doses of the HPV vaccine, (4) is not currently enrolled in another project that involves HPV-related education, and (5) agrees and provides assent to participate in research activities.
Parent sample: (1) parent or legal guardian of the participating child, (2) speak and read English, (3) own a smartphone, (4) agree to receive email and text messages, (5) is not currently enrolled in another project that involves HPV-related education, and (6) agree and provide consent to participate in research activities.
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
vaccination game
BehavioralA health game to promote HPV vaccination among youth
Treatment groups
180 Participants
are divided into 2 treatment groupsGroup A: HPV game groupExperimental treatment 1 intervention
Group B: Usual careNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Percentage of eligible individuals agreeing to participate
Assessed by the % of eligible individuals agreeing to participate
Time frame
T0 (occurs after consenting and before assigning to different study conditions)2
Proportion of participants who are retained through follow-up
Assessed by the % of participants who are retained through follow-up
Time frame
T2 (occurs two months after completion of the intervention)3
Percentage of participants who complete the intervention and assessments
Assessed by the % of participants who complete the intervention and assessments
Time frame
T2 (occurs two months after completion of the intervention)4
Participant satisfaction with the project
Assessed by two Likert scale questions: (1) are you satisfied with the program? (2) Will you recommend this program to others? Responses: from (1) very dissatisfied/definitely not to (5) very satisfied/definitely yes)
Time frame
T2 (occurs two months after completion of the intervention)Secondary outcomes
1
Children receives the first dose of HPV vaccine
Assessed by one binary question regarding whether or not the child has received the first dose of HPV vaccine. Responses: yes, no
Time frame
T2 (occurs two months after completion of the intervention)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov